Preferred Name |
Terazosin |
|
Synonyms |
Terazosina Kern |
|
ID |
http://purl.bioontology.org/ontology/MESH/C041226 |
|
altLabel |
Terazosina Kern Flotrin A 45975 Tazusin Terazosina Qualix Deflox Apo-Terazosin Heitrin Hytrin BPH ratio-Terazosin Terazosin AZU Nu-Terazosin Magnurol terazosin hydrochloride anhydrous Sutif Hytrine Terazoflo Dysalfa Novo-Terazosin Terazosin Hexal terazosin, monohydrochloride, dihydrate Adecur Hytrin Terazosin hydrochloride Terazosina Alter Zayasel PMS-Terazosin |
|
cui |
C1529003 C1528996 C1170444 C1528994 C1528995 C1170574 C1529002 C1529001 C1528968 C2241271 C0591628 C0076107 C1529000 C1528999 C1170063 C1170496 C0770137 C1170451 C1528998 C2936774 C1528997 C1528969 |
|
Has mapping qualifier | ||
HM |
D011224/Q000031 |
|
Inverse of RB |
8QOP8Z9955 D32S14F082 8L5014XET7 0 |
|
isa | ||
LT |
TRD |
|
Mapped to | ||
MDA |
19840531 |
|
MeSH Frequency |
614 |
|
MMR |
20161221 |
|
notation |
C041226 |
|
PA |
D058668 D064804 |
|
PI |
*PIPERAZINES (84-85) |
|
prefLabel |
Terazosin |
|
RR |
8QOP8Z9955 63590-64-7 (Terazosin) D32S14F082 |
|
SC |
1 |
|
Scope Statement |
induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia |
|
SRC |
Acta Physiol Scand 1984;120(1):37 NZ Med J 1981;94(688):67 |
|
TERMUI |
T844491 T619592 T619496 T619608 T619590 T619594 T619498 T619584 T733044 T619602 T619598 T152363 T619596 T619588 T733042 T734239 T619494 T619491 T619492 T619488 T619490 T619600 T619606 T619586 T619604 T733043 T619610 T619489 |
|
TH |
US MX UK NL CA FDA SRS (2013) FDA SRS (2014) ES USAN (19XX) INN (19XX) NLM (2010) DE AU NLM (2014) FR IE |
|
tui |
T109 T121 |